Hematopoietic System
16 cases on [genuine one-line description of what this topic's real clinical territory covers] — choose a case below to open its full multi-voice debate.
A single patient, iron-deficient during an active Crohn flare. The disagreement isn't about whether she needs iron — it's about whether her own inflamed gut can be trusted to absorb it.
A single patient on hemodialysis, asking for real relief from real fatigue. The disagreement isn't whether his hemoglobin could go higher — it's how much higher is actually safe for a man with his cardiac history.
Two independent patients, the same severe aplastic anemia. The disagreement isn't about the disease — it's about whether a matched donor and three fewer decades of life change which therapy actually serves each of them best.
A single patient, still crisis-prone despite optimized hydroxyurea. The disagreement isn't the usual escalation menu — one of the two drugs that menu used to include is gone entirely, and the other is still prescribable on a confirmatory trial that missed.
Two independent patients, both seeking a cure for severe sickle cell disease. The disagreement isn't whether to pursue curative therapy — it's which one, once a matched sibling is or isn't part of the picture.
A single patient, transfusion-dependent since infancy, with a matched sibling ready to donate. The disagreement isn't whether he can be cured — it's whether his sister should be the one who makes that possible.
A single patient, failing steroid tapers twice over. The disagreement isn't whether she needs second-line therapy — it's whether to reach first for the reversible option or the historically more durable one.
A single patient, whose hemolysis is reliably tied to a hobby he won't give up. The disagreement isn't whether he needs therapy before winter — it's whether speed or an eventual exit matters more.
A single patient, well-controlled by the number that usually matters most. The disagreement isn't whether her therapy is working — it's whether the wrong number is the one being watched.
A single patient, found incidentally with a striking hematocrit. The disagreement isn't whether he needs treatment now — it's how hard to chase a diagnosis before treating the number in front of us.
Two related patients, the identical hereditary hemochromatosis genotype. The disagreement isn't about the mutation — it's about whether a genotype that hasn't become disease should be treated as though it already has.
A single patient, flagged by a threshold that assumes one normal baseline for everyone. The disagreement isn't whether his neutrophil count is genuinely low — it's whether low, for him, means what it would mean for someone else.
A single patient, with numbness and gait changes that argue for treating today. The disagreement isn't whether she has a B12 problem — it's whether folate can be given safely alongside it or must wait.
A single patient, a decade into a transfusion schedule she has never controlled. The disagreement isn't whether mitapivat might help — it's whether now is the right moment to find out.
A single patient, whose disease is controlled but whose treatment has started costing him real ground. The disagreement isn't whether to add mepolizumab — it's whether it actually replaces his steroid burden or just sits alongside it.
A single patient, critically ill with an already-suppressed marrow. The disagreement isn't whether he needs urgent therapy — it's whether the best-proven regimen is still the right one once his own marrow reserve is factored in.